Samit Hirawat
InvestorMedical Advisor at Abingworth
Find your path to Samit
50 people in our graph share verified history with Samit — schools, employers, funds. One of them is your warm intro.
About
Samit Hirawat, M.D., joined Abingworth in June 2026 as Medical Advisor, bringing background in drug development. He previously served as Chief Medical Officer and Head of Global Drug Development at Bristol Myers Squibb, overseeing product development across therapeutic areas, and earlier held senior roles at Novartis (EVP and Head of Oncology Development), PTC Therapeutics, and Pfizer. He earned his MBBS at Sawai Man Singh Medical College in India and completed internal medicine residency and medical oncology training at North Shore University Hospital in New York.
Invests in
Biotech
Investments
Board seats
Cytospire TherapeuticsK-2 Therapeutics, LLCPacira Biosciences
Per the firm's website.
Colleagues at Abingworth
Frequently asked questions
- Who is Samit Hirawat?
- Samit Hirawat, M.D., joined Abingworth in June 2026 as Medical Advisor, bringing background in drug development. He previously served as Chief Medical Officer and Head of Global Drug Development at Bristol Myers Squibb, overseeing product development across therapeutic areas, and earlier held senior roles at Novartis (EVP and Head of Oncology Development), PTC Therapeutics, and Pfizer. He earned his MBBS at Sawai Man Singh Medical College in India and completed internal medicine residency and medical oncology training at North Shore University Hospital in New York.
- Where does Samit Hirawat work?
- Samit Hirawat is Medical Advisor at Abingworth.
- What does Samit Hirawat invest in?
- Samit Hirawat invests in Biotech.
- What boards does Samit Hirawat sit on?
- Samit Hirawat holds tracked board seats at Cytospire Therapeutics, K-2 Therapeutics, LLC, Pacira Biosciences.